Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells

Free Radical Biology and Medicine

Volumn 44, Issue 4, 2008, Pages 506-517

  Brodeur, Mathieu R ^a   Brissette, Louise ^a   Falstrault, Louise ^a   Ouellet, Pascale ^a   Moreau, Robert ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Cell death; Cholesteryl ester; Low density lipoprotein; Osteoblast; OxLDL; Proliferation; Selective uptake

Indexed keywords

ACRIDINE; CHLOROQUINE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR DISEASE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEGRADATION; HUMAN; HUMAN CELL; INTERNALIZATION; LIPID METABOLISM; LIPID OXIDATION; LYSOSOME; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; HUMANS; LIPOPROTEINS, LDL; LYSOSOMES; MICE; OSTEOBLASTS; OSTEOPOROSIS; OXIDATION-REDUCTION; TETRAZOLIUM SALTS; THIAZOLES;

EID: 38649110396     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.08.030     Document Type: Article

References (50)

1. Rodan G.A., and Martin T.J. Therapeutic approaches to bone diseases. Science 289 (2000) 1508-1514
2. Kodama H., Nose M., Niida S., and Yamasaki A. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J. Exp. Med. 173 (1991) 1291-1294
3. Akatsu T., Murakami T., Nishikawa M., Ono K., Shinomiya N., Tsuda E., Mochizuki S., Yamaguchi K., Kinosaki M., Higashio K., Yamamoto M., Motoyoshi K., and Nagata N. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. Biochem. Biophys. Res. Commun. 250 (1998) 229-234
4. Udagawa N., Takahashi N., Yasuda H., Mizuno A., Itoh K., Ueno Y., Shinki T., Gillespie M.T., Martin T.J., Higashio K., and Suda T. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141 (2000) 3478-3484
5. Barengolts E.I., Berman M., Kukreja S.C., Kouznetsova T., Lin C., and Chomka E.V. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif. Tissue Int. 62 (1998) 209-213
6. Uyama O., Yoshimoto Y., Yamamoto Y., and Kawai A. Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 28 (1997) 1730-1732
7. Shiraki M., Shiraki Y., Aoki C., Hosoi T., Inoue S., Kaneki M., and Ouchi Y. Association of bone mineral density with apolipoprotein E phenotype. J. Bone Miner. Res. 12 (1997) 1438-1445
8. Castelli W.P., Doyle J.T., Gordon T., Hames C.G., Hjortland M.C., Hulley S.B., Kagan A., and Zukel W.J. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 55 (1977) 67-72
9. Laroche M., Pouilles J.M., Ribot C., Bendayan P., Bernard J., Boccalon H., and Mazieres B. Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin. Rheumatol. 13 (1994) 61-64
10. Parhami F., Tintut Y., Beamer W.G., Gharavi N., Goodman W., and Demer L.L. Atherogenic high-fat diet reduces bone mineralization in mice. J. Bone. Miner. Res. 16 (2001) 182-188
11. Edwards C.J., Hart D.J., and Spector T.D. Oral statins and increased bone-mineral density in postmenopausal women. Lancet 355 (2000) 2218-2219
12. Meier C.R., Schlienger R.G., Kraenzlin M.E., Schlegel B., and Jick H. Statin drugs and the risk of fracture. JAMA 284 (2000) 1921-1922
13. Schoofs M.W., Sturkenboom M.C., van der Klift M., Hofman A., Pols H.A., and Stricker B.H. HMG-CoA reductase inhibitors and the risk of vertebral fracture. J. Bone Miner. Res. 19 (2004) 1525-1530
14. Rizzo M., Di Fede G., Mansueto P., Castello F., Carmina E., and Rini G.B. Statins and osteoporosis: myth or reality?. Minerva Med. 95 (2004) 521-527
15. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272 (1997) 20963-20966
16. Parhami F., Morrow A.D., Balucan J., Leitinger N., Watson A.D., Tintut Y., Berliner J.A., and Demer L.L. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 680-687
17. Mody N., Parhami F., Sarafian T.A., and Demer L.L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic. Biol. Med. 31 (2001) 509-519
18. Klein B.Y., Rojansky N., Ben-Yehuda A., Abou-Atta I., Abedat S., and Friedman G. Cell death in cultured human Saos2 osteoblasts exposed to low-density lipoprotein. J. Cell. Biochem. 90 (2003) 42-58
19. Brodeur M.R., Falstrault L., Brissette L., and Moreau R. Expression of class B Scavenger receptors by osteoblastic cells: A new pathway for the routing of cholesterol and estradiol to bone cells (abstract). Bone 41 (2007) S215
20. Acton S.L., Rigotti A., Landschultz K.T., Xu S., Hobbs H.H., and Krieger M. Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science 271 (1996) 518-520
21. Nicholson A.C., Frieda S., Pearce A., and Silverstein R.L. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 269-275
22. Brown M.S., and Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232 (1986) 34-47
23. Goldstein J.L., and Brown M.S. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J. Biol. Chem. 249 (1974) 5153-5162
24. Brissette L., Charest M.C., and Falstrault L. Selective uptake of cholesteryl esters of low-density lipoproteins is mediated by the lipoprotein-binding site in HepG2 cells and is followed by the hydrolysis of cholesteryl esters. Biochem. J. 318 (1996) 841-847
25. Green S.R., and Pittman R.C. Selective uptake of cholesteryl esters from low density lipoproteins in vitro and in vivo. J. Lipid Res. 32 (1991) 667-678
26. Rhainds D., Falstrault L., Tremblay C., and Brissette L. Uptake and fate of class B scavenger receptor ligands in HepG2 cells. Eur. J. Biochem. 261 (1999) 227-235
27. Gillotte-Taylor K., Boullier A., Witztum J.L., Steinberg D., and Quehenberger O. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J. Lipid Res. 42 (2001) 1474-1482
28. Podrez E.A., Febbraio M., Sheibani N., Schmitt D., Silverstein R.L., Hajjar D.P., Cohen P.A., Frazier W.A., Hoff H.F., and Hazen S.L. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J. Clin. Invest. 105 (2000) 1095-1108
29. Nozaki S., Kashiwagi H., Yamashita S., Nakagawa T., Kostner B., Tomiyama Y., Nakata A., Ishigami M., Miyagawa J., and Kameda-Takemura K. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J. Clin. Invest. 96 (1995) 1859-1865
30. Langer T., Strober W., and Levy R.I. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J. Clin. Invest. 51 (1972) 1528-1536
31. McFarlane A.S. Efficient trace-labeling of proteins with iodine. Nature 182 (1948) 53-54
32. Roberts D.C., Miller N.E., Price S.G., Crook D., Cortese C., La Ville A., Masana L., and Lewis B. An alternative procedure for incorporating radiolabelled cholesteryl ester into human plasma lipoproteins in vitro. Biochem. J. 226 (1985) 319-322
33. Lougheed M., and Steinbrecher U.P. Mechanism of uptake of copper-oxidized low density lipoprotein in macrophages is dependent on its extent of oxidation. J. Biol. Chem. 271 (1996) 11798-11805
34. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
35. Podrez E.A., Schmitt D., Hoff H.F., and Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest. 103 (1999) 1547-1560
36. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87 (1990) 1620-1624
37. Graham A.N., Hogg N., Kalyanaraman B., O'Leary V., Darley-Usmar V., and Moncade S. Peroxynitrite modifications of LDL leads to recognition by the macrophage scavenger receptor. FEBS Lett. 330 (1989) 181-186
38. Bourret G., Brodeur M.R., Luangrath V., Lapointe J., Falstrault L., and Brissette L. In vivo cholesteryl ester selective uptake of mildly and standardly oxidized LDL occurs by both parenchymal and nonparenchymal mouse hepatic cells but SR-BI is only responsible for standardly oxidized LDL selective uptake by nonparenchymal cells. Int. J. Biochem. Cell Biol. 38 (2006) 1160-1170
39. Salvayre R., Auge N., Benoist H., and Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta 1585 (2002) 213-221
40. Chisolm G.M., and Chai Y. Regulation of cell growth by oxidized LDL. Free Radic. Biol. Med. 28 (2000) 1697-1707
41. Owen T.A., Aronow M., Shalhoub V., Barone L.M., Wilming L., Tassinari M.S., Kennedy M.B., Pockwinse S., Lian J.B., and Stein G.S. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 143 (1990) 420-430
42. Stein G.S., Lian J.B., and Owen T.A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 4 (1990) 3111-3123
43. Maor I., and Aviram M. Oxidized low density lipoprotein leads to macrophage accumulation of unesterified cholesterol as aresult of lysosomal trapping of the lipoprotein hydrolyzed cholesteryl ester. J. Lipid Res. 35 (1994) 803-809
44. Maor I., Mandel H., and Aviram M. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-ketocholesterol. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1378-1387
45. Lougheed M., Zhang H., and Steinbrecher U. Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. J. Biol. Chem. 266 (1991) 14519-14525
46. Hoppe G., O'Neil J., and Hoff H. Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages. J. Clin. Invest. 94 (1994) 1506-1512
47. Jessup W., Mander E.L., and Dean R.T. The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Biochim. Biophys. Acta 1126 (1992) 167-177
48. Boya P., Andreau K., Poncet D., Zamzami N., Perfettini J.L., Metivier D., Ojcius D.M., Jaattela M., and Kroemer G. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J. Exp. Med. 197 (2003) 1323-1334
49. Li W., Yuan X.M., Olsson A.G., and Brunk U.T. Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 177-184
50. Ehara S., Ueda M., Naruko T., Haze K., Itoh A., Otsuka M., Komatsu R., Matsuo T., Itabe H., Takano T., Tsukamoto Y., Yoshiyama M., Takeuchi K., Yoshikawa J., and Becker A.E. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103 (2001) 1955-1960